Fundraising Fox

Fluoropharma Medical

Montclair, US · Nevada corporation

Biotech

Founders & leadership

TR
Tamara RheinExecutive
J(
Johan (Thijs) M. SpoorExecutive
J(
Johan (Thjis) SpoorExecutive

Board

LM
Lawrence M. AtinskyBoard director
AH
Andrew H. SassineBoard director
WW
Walter WitoshkinBoard director
JA
Joseph A. PierroBoard director
PS
Peter S. ContiBoard director

Reported raises · per SEC filings

Form D private placements

$2.6M disclosed across 4 rounds · 2013–2016

▶$150KraisedApr 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Walter WitoshkinDirector
  • W. Austin LewisDirector
  • Thomas H. TulipExecutive Officer, Director
  • Peter S. ContiDirector
  • Tamara RheinExecutive Officer
  • Johan (Thijs) M. SpoorDirector
  • Lawrence H. AtinskyDirector
Offering amount
$1M
Amount sold
$150K
First sale
Mar 2016
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$350KraisedJun 2015 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Walter WitoshkinDirector
  • Lawrence M. AtinskyDirector
  • Andrew H. SassineDirector
  • Tamara RheinExecutive Officer
  • Joseph A. PierroDirector
  • Johan (Thijs) M. SpoorExecutive Officer, Director
  • Peter S. ContiDirector
Offering amount
$2M
Amount sold
$350K
Sales commissions
$28K
Placement agents
Highline Research Advisors LLC
First sale
May 2015
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJul 2014 · 23 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph A. PierroDirector
  • Johan (Thijs) M. SpoorExecutive Officer, Director
  • Lawrence AtinskyDirector
  • Peter S. ContiDirector
  • Andrew H. SassineDirector
  • Walter WitoshkinDirector
  • Tamara RheinExecutive Officer
Offering amount
$2M
Amount sold
$1.2M
Sales commissions
$81.6K
Placement agents
Monarch Capital Group LLC
First sale
Jul 2014
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$877.5KraisedJan 2014 · 16 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Walter WitoshkinDirector
  • Tamara RheinExecutive Officer
  • Peter S. ContiDirector
  • Lawrence AtinskyDirector
  • Joseph PierroDirector
  • Johan (Thjis) SpoorExecutive Officer, Director
Offering amount
$2M
Amount sold
$877.5K
Sales commissions
$69.4K
Placement agents
Brookline Group LLC
First sale
Dec 2013
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Fluoropharma Medical raised?
Fluoropharma Medical has disclosed $2.6M raised across 4 rounds.
Where is Fluoropharma Medical headquartered?
Fluoropharma Medical is headquartered in Montclair, US.